FIELD: medical devices.
SUBSTANCE: invention relates to compositions of high-molecular compounds, namely to biodegradable compositions of high-molecular compounds using phosphorus-containing compounds as components, and can be used for 3D printing of medical products. Polymer composite material for 3D printing of medical products contains ε-polycaprolactone with a number average molecular weight of 70,000–90,000 g/mol, hydroxyapatite with a particle size of 100–20,000 nm and polysorbate 20 in the following component ratio, wt.%: 76–98 of ε-polycaprolactone, 1–21 of hydroxyapatite, 1–3 of polysorbate 20.
EFFECT: obtaining a polymer composite material for 3D printing of medical products with elastic properties.
1 cl, 2 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PRODUCING POLYMER COMPOSITE MATERIAL FOR MAKING MEDICAL PRODUCTS | 2023 |
|
RU2815644C1 |
COMPOSITE FOR 3D-PRINTING OF MEDICAL PRODUCTS | 2018 |
|
RU2679632C1 |
COMPOSITE FOR 3D-PRINTING OF MEDICAL PRODUCTS | 2018 |
|
RU2679127C1 |
POLYMER COMPOSITE WITH SHAPE MEMORY EFFECT FOR 3D-PRINTING OF MEDICAL EQUIPMENT | 2016 |
|
RU2631890C1 |
METHOD OF PURIFYING POLYCAPROLACTONE FROM TIN IMPURITIES | 2023 |
|
RU2824007C1 |
BIOACTIVE POLYMER POROUS STENTS | 2016 |
|
RU2665175C2 |
BIOACTIVE POLYMER THREAD FOR IMPLEMENTING LAYER-BY-LAYER 3D PRINT | 2015 |
|
RU2637841C2 |
COMPOSITE FILAMENTS OF SULPHONATED POLYESTER AND SILVER NANOPARTICLES COATED WITH A POLYMER, AND METHODS OF PRODUCING SAME | 2017 |
|
RU2742118C2 |
HYDROGEL FOR PRODUCTION OF COMPOSITE MATERIALS WITH ANTIBACTERIAL ACTIVITY FOR OSTEOCHONDRAL DEFECTS SUBSTITUTION BY 3D-PRINTING METHOD | 2016 |
|
RU2632431C2 |
COMPOSITE FILAMENTS FROM SULPHONATED POLYESTER AND SILVER NANOPARTICLES AND METHODS FOR PRODUCTION THEREOF | 2017 |
|
RU2742117C2 |
Authors
Dates
2024-02-15—Published
2023-11-29—Filed